Bimeda Groups news from FiercePharma
News
ALSO NOTED: Teva's Accupril gets FDA OK; Elder Pharmaceuticals buys Biomeda;
> Teva has nabbed an OK from the FDA for its generic form of Accupril, Pfizer's high blood pressure remedy. Total U.S. sales of the drug--branded and generic forms--amounted to $150 million for Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends